Like most young adults, Christopher Depace wanted to get his driver’s license but found himself initially unable to do so because of ocular albinism and congenital nystagmus, conditions affecting his vision.

Although scientists have made strides in their understanding of the Zika virus and treatments, National Institute of Allergy and Infectious Diseases warns it would be premature to consider the pandemic over.

The new year is a time for resolutions, so Johns Hopkins University is recommending ways to stay healthy and commit to improved wellness.

Just because stress is a non-negotiable part of life doesn't mean it needs to rule your existence, according to Johnson & Johnson, so the company recently offered strategies for easing post-holiday strains.

Researchers at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and the Memorial Sloan Kettering Cancer Center recently sought to understand the subtleties involved in individuals’ response to cancer.

The Centers for Medicare & Medicaid Services (CMS) recently said that practitioners partaking in the Quality Payment Program can record and input performance data from 2017 using CMS’s new website section.

Four decades after the first Ebola outbreak, experts at the University of California at Los Angeles (UCLA) Fielding School of Public Health have determined that original surviving victims developed a degree of immunity against potential future infection.

Biotechnology Innovation Organization (BIO) has thanked Sen. Thom Tillis (R-NC) and Sen. Gary Peters (D-MI) for introducing the Fostering Innovation Act, according to a company press release

Add Teaser here

In a collaboration with Cleveland Clinic, Select Medical Corp. recently opened the doors to its new 60-bed, state-of-the-art inpatient facility, Cleveland Clinic Rehabilitation Hospital, Beachwood, which offers specialty care to Ohio patients recovering from complex conditions.

Johnson & Johnson said it is seeking nominations for its Dr. Paul Janssen Award for Biomedical Research, which includes a $200,000 cash prize to researchers and scientists whose work has made significant contributions to improving human health.

Orthopedic injuries, hypothermia, and other adverse health events may result from severe weather conditions such as the “bomb cyclone” lately sweeping the nation, according to emergency room physicians describing a recent uptick in winter-related ER cases.

H. Lundbeck A/S, a Danish pharmaceutical firm focused on psychiatric and neurological treatments, recently announced its partnership with Vanderbilt University to license and advance collaborative research for treating schizophrenia cases.

With a childhood history of “a gazillion sunburns” and following multiple surgeries for melanoma, Massachusetts-based writer Martha Pfeiffer qualified for a pioneering Dana-Farber Cancer Institute study isolating patients’ tumor cell DNA for personalized vaccination potential.

Presenting a potentially pioneering approach to Rett syndrome, a severe chromosomal disorder that affects females, Massachusetts General Hospital (MGH) recently published study results suggesting that genetic reactivation might serve as a key to a remedy.

Chadwick Matlin, a staff writer for the evidence-based fivethirtyeight.com, recently revealed his unexpected discovery of solace in the practice of mindfulness after experiencing initial skepticism – especially given the practice’s highly trending profile of late.

Johnson & Johnson Innovation recently launched over a dozen new collaborations to impact health care, marking more than 350 partnerships since the company's establishment in 2012.

Hospital costs suffer from a deep lack of transparency, but a new "eye opening" report that reveals one common procedure costs nearly eight times more in one Minnesota facility than at another will help to inform policy debate, according to Minnesota's health economist.

Merck said Lynparza (olaparib), a targeted therapy co-developed with AstraZeneca, has become the first PARP inhibitor approved by the Food and Drug Administration for treating metastatic breast cancer.

University of Florida neuroscientists recently determined that individuals with Tourette syndrome may benefit from deep brain stimulation (DBS) which has previously been proven effective with other movement disorders, including Parkinson’s disease.